ERBB2 and non-small cell lung carcinoma: Second, although this study provided a comprehensive evaluation of all available treatment options and RC48 showed excellent antitumor activity in HER2-altered NSCLC, the small sample size reduces the statistical power and caution should be exercised in interpreting these results.